{
  "id": 4559029,
  "title": "Aletta: The Robot That Can Now Draw Blood Without Human Hands",
  "url": "https://urgent.news/2026/08/31/aletta-the-robot-that-can-now-draw-blood-without-human-hands",
  "topic": "tech",
  "section": "Tech",
  "published": "2026-08-31T03:00:00.000Z",
  "source": {
    "name": "Colombia One",
    "slug": "colombia-one",
    "url": "https://colombiaone.com/2026/08/30/aletta-robot-draw-blood/"
  },
  "original_language": "en",
  "account": "The U.S. Food and Drug Administration (FDA) has officially approved Aletta, a robotic device that can now draw blood from patients without direct human intervention. This marks a significant step in the automation of routine medical procedures, as Aletta becomes the first stand-alone robotic device authorized for autonomous blood draws. The FDA granted marketing authorization through its De Novo pathway, a route reserved for novel devices without an existing legally marketed equivalent. Vitestro, a Dutch medical technology company, developed Aletta, and its application for approval was submitted in September 2025 and approved on August 19, 2026.\n\nAletta combines robotic precision with human supervision during the blood collection process. It utilizes near-infrared imaging, ultrasound, and Doppler ultrasound to locate and identify suitable veins, ensuring the needle is inserted into a safe and appropriate vessel. The supervising professional remains present throughout the procedure, responsible for monitoring the process, ensuring proper tube filling, and verifying the collected blood volume. While Aletta can perform the technical aspects of venipuncture autonomously, it cannot be used for blood donation purposes. The FDA emphasizes that Aletta is designed to alleviate staffing shortages and improve the efficiency of blood collection services, without compromising safety standards. The device has undergone rigorous testing, including clinical data from diverse patient populations, to ensure its accuracy and safety.",
  "summary": "One of medicine’s most routine procedures is entering a new era of automation. The U.S. Food and Drug Administration (FDA) authorized Aletta on August 19, 2026, the first autonomous, stand-alone robotic device capable of drawing blood from a person’s arm without an operator directly manipulating the needle during the procedure. The decision creates a new […]",
  "key_points": [
    "FDA approves Aletta, first autonomous robotic blood draw device",
    "Vitestro developed Aletta using near-infrared imaging and Doppler ultrasound",
    "Aletta aids staffing shortages and improves blood collection efficiency"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}